As of Apr 17
| -0.94 / -1.62%|
The 5 analysts offering 12-month price forecasts for AMAG Pharmaceuticals Inc have a median target of 55.00, with a high estimate of 65.00 and a low estimate of 41.00. The median estimate represents a -3.88% decrease from the last price of 57.22.
The current consensus among 5 polled investment analysts is to Buy stock in AMAG Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.